Upcoming Webinar :Register now for 'ULIP as an investment during economic recovery' powered by Bajaj Allianz

Slideshow | HDFC Securities Picks 6 Stocks That Can Return Up To 73%

Here are the portfolio stock ideas from HDFC Securities, which could give up to 73 percent upside.

Apr 15, 2020 / 10:56 AM IST
Here are the seven portfolio stock ideas from HDFC Securities, which could give up to 73 percent upside.
Here are the six portfolio stock ideas from HDFC Securities that can return 22-73 percent upside.
HDFC Securities reiterated buy rating on Apollo Hospitals Enterprise with the target price to Rs 1705 at 18x to FY21E EBITDA and adjusting net debt of Rs 218 per share in FY19. It has not revised the earning estimates and target price to incorporate the impact of Covid-19. 1,280. Upside: 33 percent
HDFC Securities reiterated buy rating on Apollo Hospitals Enterprise with the target price of Rs 1,705 at 18x to FY21E EBITDA and adjusting net debt of Rs 218 per share in FY19. It has not revised the earnings estimates and target price to incorporate the impact of COVID-19. Upside: 33 percent
Picture for representation (Image: Wikimedia)
HDFC Securities put a buy raring on Bata India with a price target of Rs 1,746 which is 38x FY21E EPS of Rs 46. The company continued to improve its profitability in Q3FY20 as well on the back of improved product mix given the new launches in the premium segment and portfolio refreshes across categories. Upside: 46 percent
Infosys | M-cap for the week ended April 9: Rs 2,71,553.37 crore | Gain during the week: Rs 22,210.65 crore
Broking house has put a buy on Infosys and maintained the target price of Rs 854 at 19x FY21 EPS of Rs 42.7 and adding Rs 45 cash per share. The company’s strategy on improving productivity in the legacy business and trying to grow newer high margin services business is likely to help it to achieve better growth. CMP: Rs 637. Upside: 34 percent
HDFC Securities maintained buy rating on ITC with target price of Rs 314 at 24x FY21E EPS of Rs 13.1. Any earning/rating revision would depend on the performance of FMCG business, any regulatory changes in Cigarette business and in general business momentum. CMP: 181. Upside: 73 percent
HDFC Securities maintained buy rating on ITC with target price of Rs 314 at 24x FY21E EPS of Rs 13.1. Any earning/rating revision would depend on the performance of FMCG business, any regulatory changes in Cigarette business and in general business momentum. CMP: 181. Upside: 73 percent
Brokerage house put buy rating on TCS with a target price of Rs 2144 on 21x FY21E EPS of Rs 98.7 and adding Rs 73 cash per share. With the strong deal-flow, impressive traction in digital business, rising non-linearity in earnings and currency tailwinds, TCS is likely to deliver steady growth in the medium to long term. CMP: 1,758. Upside: 22 percent
Brokerage house put buy rating on TCS with a target price of Rs 2,144 on 21x FY21E EPS of Rs 98.7 and adding Rs 73 cash per share. With the strong deal-flow, impressive traction in digital business, rising non-linearity in earnings and currency tailwinds, TCS is likely to deliver steady growth in the medium to long term. Upside: 22 percent
8. Thyrocare Technologies: Thyrocare Technologies promoters have increased their stake in the company to 66.06 percent from 65.12 in the previous year. The stock has given 0.97 percent return YTD (Image Source: Thyrocare Technologies)
HDFC Securities maintained buy rating on Thyrocare Technologies with the target price of Rs 737 based on a PE multiple of 30x FY21E EPS of Rs.24.6. Company's well-established brand image, huge opportunity size, robust return ratios, cash-rich balance sheet and attractive valuations support the long term view. Upside: 38 percent
Moneycontrol News
first published: Apr 15, 2020 10:56 am

stay updated

Get Daily News on your Browser
Sections